AI Summary
✦ ClarthaValuation Metrics
Trading 0.0% above historical median. Valuation is stable — currently in the undervalued zone (z-score: 0). Confidence: 82%.
Forward Valuation Outlook
Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.
P/E
5Y Average
—
Current
92.88
Overvalued
116.10
Undervalued
69.66
P/B
5Y Average
—
Current
2.00
Overvalued
2.50
Undervalued
1.50
Peers & Comparison
Sector: Health Care · Theme: Pharmaceuticals
Pharmaceuticals Peers8 peers
Avg P/E: 43.8x| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
LAURUS LABS LIMITED LAURUSLABSPharmaceuticals | +29.1% | 15.0% | 91.9x Premium | +110% vs avg | +123.1% |
LARSEN & TOUBRO LTD. LTPharmaceuticals | +8.1% | 5.6% | 33.5x Undervalued | -24% vs avg | +10.7% |
MANKIND PHARMA LIMITED MANKINDPharmaceuticals | +12.9% | 13.9% | 49.5x Fair | +13% vs avg | +0.3% |
GLENMARK PHARMACEUTICALS GLENMARKPharmaceuticals | +23.1% | 10.1% | 35.7x Undervalued | -18% vs avg | +9.4% |
ABBOTT INDIA LIMITED ABBOTINDIAPharmaceuticals | +6.5% | 22.4% | 38.4x Fair | -12% vs avg | -15.4% |
IPCA LABORATORIES LTD IPCALABPharmaceuticals | +6.3% | 11.8% | 38.8x Fair | -11% vs avg | +22.5% |
AJANTA PHARMA LIMITED AJANTPHARMPharmaceuticals | +24.8% | 19.6% | 38.6x Fair | -12% vs avg | +30.0% |
ZYDUS LIFESCIENCES LTD ZYDUSLIFEPharmaceuticals | +16.2% | 18.6% | 23.8x Undervalued | -46% vs avg | +17.1% |
WHY THESE PEERS
Comparable-scale peer data is limited — showing nearest stored business/industry peers instead of an empty comparison.
Financials
Financial chart data is not available for this company right now.
Results
Income statement data not available.
All values in ₹ Crores unless otherwise stated. Source: Company filings.